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• The Helsinki Declaration of the World Medical Association continues to provide an essential guidance for researchers, drafters of protocols of clinical studies, and for ethical review, and has in Slovenia a de facto status of obligatory guideline.
Thus, the current practice in assuring observance of ethical principles in biomedical research to a large extent relies on the Helsinki Declaration (World Medical Association, Declaration of Helsinki: Recommendations Guiding Physicians in Biomedical Research Involving Human Subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964) , on the Oviedo Convention and the provisions of the Draft Protocol to the Oviedo Convention, on biomedical research. The National Medical Ethics Committee (NMEC), which reviews most of the biomedical research on human subjects, is the main body responsible for ethics of biomedical research in Slovenia. The ethical committees within the regional hospitals are authorized to review local studies not presenting any serious risk or burden, for example, noninvasive and observational research. Ethical review is required for all research involving intervention on, or interaction with human beings. Additionally, it is required for all research on personal medical data, and biological material of human origin.
All research involving intervention on or interaction with living persons has to be reviewed and approved before the actual work may be started. This also applies to research on biological materials of human origin, i.e., tissue and blood samples, both prospectively collected and archived, even if anonymous. Ethical review is also obligatory for research on personal medical data, including epidemiological studies. Sociological and psychological studies based on questionnaires, which invade privacy with potential harmful effects for persons involved, are also subject to ethical review.
It is common practice of the NMEC to require the consent in all cases of direct intervention on, or interaction with, persons concerned. In principle, informed consent is also required for research on archived personal medical data or biological samples. This requirement may be waived by the NMEC if seeking consent would involve unreasonable efforts and in as far as the risk of undue invasion of privacy is minimal. In some cases of so-called observational research, where data is rendered anonymous and where there is no possibility of violation of human rights, in particular the right to private life, informed consent is not needed. It is, however, for the research ethics committee to decide whether the duty of obtaining consent is there or not.
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Consent by the person concerned may not be sufficient when he/she is legally or de facto incompetent or unable to take decisions in his/her best interest. Such is the case with children and adolescents below the age of legal competence or persons with a mental disorder.
Children are considered legally competent beyond the age of 15 (Law on health services, Art. 47/II). For younger children where authorisation is sought from their legal representatives, the NMEC requires that the child takes part in the decision process (Article 17 of the Draft Research Protocol). Research on a child who objects to the procedures proposed may not be started nor continued. An adult not able to consent, e.g. because of a mental disorder, must be allowed to take part in the authorisation procedure as far as possible (Article 17 of the Draft Research Protocol).
No specific national regulations exist in regard research involving human biological material, except for the ones related to blood transfusion and organ transplantation. Never the less, the NMEC decided that informed consent is required for such research. However, the donors of the biological material were not considered to have a right to financial benefit (apart from reimbursement for actual expenses incurred by them), in accordance with Article 21 of the Oviedo Convention (the human body and its parts shall, as such, not be a source of financial gain). 1. The full title of the research study, including its code.
2. The name and short professional CV of the principal / responsible investigator; the institution proposing the research and the one where the research will be conducted.
3. The name and professional qualifications of the doctor responsible for safety of human subjects in the study. 14. Information for the participants or their legal representatives (in case of persons unable to consent). Risks, burdens and benefits must be properly explained in Slovene lay language.
Informed Consent form. The subject or patient must be informed that he / she has a right to refuse or later on at any time withdraw the consent without suffering any detriment. If biological samples will be collected and part of the material is to be stored for possible future 6 uses, a separate consent to this is required. The patient should usually be offered different options: not to agree to storage, to agree only to certain types of future research (e.g. excluding genetic studies), to be asked for consent to any future studies, or to give a blanket consent to all future uses. When giving authorisation for future studies, this should be with the understanding and explicit obligation that a prior approval by an independent ethics committee will be obtained.
15. Details about how the subjects / patients can contact the responsible doctor in case of emergency.
16. In research on patients in fertile period where risk exists of mutagenicity, special information on the risks and a statement by the patient / subject that appropriate measures will be taken to prevent pregnancy.
17. Date of application and signature of the proposer.
18. After approval had been issued, the Principal Investigator, the Sponsor or the CRO have a duty to inform the Committee on any changes in the protocol that may affect the ethical aspects of the study. Premature termination must be promptly reported and reasons must be given. Upon conclusion of the study, a final report on the outcomes must be supplied, even in case of a negative result.
Safety reports -until further notice
Suspected unexpected serious adverse events/reactions (SUSARs) in multinational trials recorded in the national centres must be expeditely reported. the NMEC of SUSARs by the sponsor/CRO or the responsible investigator is also required when there are reasons to suspect that risk to the participants could exceed the anticipated or acceptable level, or that the originally estimated risk/benefit ratio is unfavourably changed. This includes cases of unexpectedly frequent occurrence of the anticipated severe adverse events (SAEs). Regarding other SAEs, quarterly, semiannual or annual safety reports are sufficient. accompanied with a comment by the sponsor/CRO or the clinically responsible principal investigator. The same applies to annual safety reports. nt by e-mail to tone.zakelj@kclj.si as PDF files attached to the main message, accompanied by data needed to identify the study (e.g., reference to earlier correspondence with the NMEC).
20. In all further correspondence on the same study, quote the NMEC reference No. of the latest correspondence.
21. The above documents may be supplied in English or in Slovene language. However, items 4 (last line), 14, 15, and 16 must be in Slovene. According to the rules, the NMEC will respond in Slovene. In certain justified cases and as an exception, the opinion may be given in Children under 6 years of age with acute bronchiolitis, acute gastroenteritis and febrile convulsion that will be admitted in to the Department of Infectious Diseases, University Medical Centre Ljubljana will be included in to the study and healthy control children who will be admitted to the Department of Pediatric Surgery and Intensive Care for elective surgical procedures. All specimens will be sent to the laboratory of the Institute of The National Medical Ethics Committee is also the Governmental Medical Ethics
Committee, therefore their approval of the study is also the Governmental Approval.
Approval of the purposed study by the National Medical Ethics Committee (in Slovenian language)
